Klaus Gregorius

Biography

Klaus Gregorius co-founded MipSalus and serves as Chief Scientific Officer. Klaus brings strong innovation and scientific skills to MipSalus. Prior to co-founding MipSalus, Klaus was Manager, Biochemistry Development at Danish biotech company PreciSense where he headed a research department focussing on receptor-ligand interactions, supporting the company’s development of biosensors for blood glucose monitoring for diabetics. 1994-2003, Klaus was Research Scientist and Project Manager at the biotech company Pharmexa developing processes and analyses for therapeutic vaccine candidates (cancer and inflammatory diseases). Klaus has published 10 peer reviewed articles and is the named inventor of 17 patent applications. His background also includes a position as visiting Research Fellow at Linnaeus University, Kalmar. Klaus was born in 1961 and holds an MSc in Biochemistry from the University of Copenhagen and a PhD in Chemistry from the Royal Danish Veterinary and Agricultural University (today: Faculty of Science under the University of Copenhagen). 

Research Interest

Pharmaceutical Sciences